skip to Main Content

AIM-HI Portfolio Company Profile: Rasio Therapeutics

  • August 10, 2020
  • Blog

Serial entrepreneur Ken Malone, Ph.D., and his team of scientists and business executives are at the forefront of developing cutting-edge biohealth companies. Malone is the Chairman of the Board of Directors of Rasio Therapeutics, a start-up which is bringing innovative…

AIM-HI Portfolio Company Profile: Tvardi Therapeutics

  • July 29, 2020
  • Blog

Imran Alibhai, Ph.D., is the CEO of Tvardi Therapeutics, a biopharmaceutical company developing breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. The National Foundation for Cancer Research and AIM-HI Accelerator Fund have been early financial supporters of…

AIM-HI Portfolio Company Profile: InterLeukin Combinatorial Therapies

  • July 22, 2020
  • Blog

Paul Fisher, M.Ph., Ph.D., co-founded InterLeukin Combinatorial Therapies with hopes of developing a product that destabilizes and kills cancer cells. The Director of Virginia Commonwealth University’s Institute of Molecular Medicine, Fisher represents a world-class scientist with knowledge also of how…

Meet Rose Wang

  • July 10, 2020
  • Blog

Rose Wang is a serial entrepreneur who helps other individuals and teams—including female cancer researchers—start their own businesses and make them thrive. Wang is the founder of Binary Group, a consulting and business solutions firm. She also currently serves as Executive…

Meet Charlie Weatherspoon

The National Foundation for Cancer Research is a "special organization," says Charlie Weatherspoon, Co-founder and Chairman of the Board of the AIM-HI Accelerator Fund (AIM-HI), which has a strong relationship with NFCR. Weatherspoon contrasts the grassroots efforts at NFCR and…

AIM-HI Portfolio Company Profile: Yiviva

Mr. Peikwen Cheng is Co-founder and CEO of Yiviva, a biotechnology start-up that develops first-in-class therapeutics. The company developed YIV906, an herbal mixture based on an 1,800-year-old Chinese formula. A number of clinical studies show YIV906 reduces the harmful adverse…

intro blog featured image

Introducing the Women’s Venture Competition

  • April 27, 2020
  • Blog

In 1975 the United Nations General Assembly designated March 8 as International Women's Day.  While the original focus was about celebrating the economic, political, and social achievements of women, to many this has become simply an occasion for men to…

Back To Top